C2orf55 Inhibitors

LY294002 is a compound that interferes with the PI3K/AKT pathway, a central signal transduction pathway that regulates cell growth and survival, and could downregulate proteins activated by this route. SB431542 acts on the TGF-β pathway, which is implicated in cell differentiation and proliferation, potentially altering the function of proteins within this signaling network. PD98059 and U0126 are both MEK inhibitors and could therefore impede proteins downstream of the MAPK/ERK pathway, which is key to cell division and differentiation. Rapamycin is an mTOR inhibitor and could influence proteins involved in protein synthesis, cell growth, and autophagy, while Triciribine targets AKT specifically and could have an impact on cell survival signaling. PP2, as a Src family kinase inhibitor, could affect various proteins involved in signal transduction related to cell growth and differentiation.

SP600125 inhibits JNK, which is involved in cellular stress responses, potentially affecting any protein that is regulated by stress or inflammatory signals. Y-27632, by inhibiting ROCK, could impact cell shape, motility, and possibly proteins that interact with the cytoskeleton. Dorsomorphin, as an AMPK inhibitor, could alter the activity of proteins involved in metabolic pathways and energy balance. BAPTA-AM, by chelating intracellular calcium, could influence proteins that are calcium-dependent, while MG132, a proteasome inhibitor, could prevent the degradation of proteins, thus potentially affecting the overall protein turnover, including C2orf55.